Kura Oncology (KURA) Interest Coverage Ratio Growth (3y) (2013 - 2014)
Kura Oncology (KURA) Interest Coverage Ratio Growth (3y) (2013 - 2014) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,015.37 Bn | 1,015.37 Bn | - | - |
| 4 | BeOne Medicines | 471.39 Bn | 466.59 Bn | 1.35 Bn | 28.11% |
| 5 | Vertex Pharmaceuticals | 122.52 Bn | 115.28 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 70.33 Bn | 61.58 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | 40.09% |
| 10 | Kura Oncology | 929.96 Mn | 929.96 Mn | 18.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 68.92% |
| Sep 30, 2014 | 21.46% |
| Jun 30, 2014 | 21.15% |
| Mar 31, 2014 | 19.12% |
| Dec 31, 2013 | 28.95% |
| Sep 30, 2013 | 30.50% |